ALLISON ANDREAS: Open Payments
NPI 1972007250 · LA CROSSE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,269 in 57 payments from 15 companies in 2025. Trend: 2023 $834 · 2024 $732 · 2025 $1,269
Food & beverage: $1,249Education: $20
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 18 | $304 |
| Novo Nordisk Inc | 5 | $228 |
| E.R. Squibb & Sons, L.L.C. | 10 | $138 |
| Shockwave Medical, Inc | 1 | $129 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $122 |
| Novartis Pharmaceuticals Corporation | 4 | $82 |
| Merck Sharp & Dohme LLC | 4 | $68 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| Abbott Laboratories | 2 | $37 |
| GlaxoSmithKline, LLC. | 1 | $25 |
Products named: REPATHA, Ozempic, Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter, Kerendia, LEQVIO, VERQUVO, CAMZYOS, ELIQUIS.
Industry payments across WI — which companies pay providers there.
